Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS).

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Brain Research

• Publication date

  2015-12-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.brainres.2015.06.035PMID 26187754PMCID PMC9152639
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human glial progenitor engraftment and gene expression is independent of the ALS environment.

  2015cited by this paper
• Induced pluripotent stem cells from ALS patients for disease modeling.

  2015cited by this paper
• Necroptosis drives motor neuron death in models of both sporadic and familial ALS.

  2014cited by this paper
• Focal Transplantation of Human iPSC-Derived Glial-Rich Neural Progenitors Improves Lifespan of ALS Mice

  2014cited by this paper
• Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes.

  2014cited by this paper
• Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons.

  2014cited by this paper
• Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1.

  2014cited by this paper
• Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons.

  2014cited by this paper
• Delayed Disease Onset and Extended Survival in the SOD1G93A Rat Model of Amyotrophic Lateral Sclerosis after Suppression of Mutant SOD1 in the Motor Cortex

  2014cited by this paper
• Analysis of graft survival in a trial of stem cell transplant in ALS

  2014cited by this paper
• Intraspinal Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis: Phase 1 Trial Outcomes

  2014cited by this paper
• Tracking immune cells in vivo using magnetic resonance imaging

  2013cited by this paper
• Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis.

  2013cited by this paper
• Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model

  2013cited by this paper
• Lumbar Intraspinal Injection of Neural Stem Cells in Patients with Amyotrophic Lateral Sclerosis: Results of a Phase I Trial in 12 Patients

  2012cited by this paper
• Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes.

  2012cited by this paper
• Multimodal Actions of Neural Stem Cells in a Mouse Model of ALS: A Meta-Analysis

  2012cited by this paper
• A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

  2011cited by this paper
• Programming embryonic stem cells to neuronal subtypes.

  2011cited by this paper
• Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats.

  2011cited by this paper
• Human Glial-Restricted Progenitor Transplantation into Cervical Spinal Cord of the SOD1G93A Mouse Model of ALS

  2011cited by this paper
• Cervical Multilevel Intraspinal Stem Cell Therapy: Assessment of Surgical Risks in Gottingen Minipigs

  2011cited by this paper
• Astrocytes from Familial and Sporadic ALS Patients are Toxic to Motor Neurons

  2011cited by this paper
• Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

  2011cited by this paper
• Platform and Cannula Design Improvements for Spinal Cord Therapeutics Delivery

  2011cited by this paper
• NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration.

  2010cited by this paper
• Isolation, characterization and preclinical development of human glial-restricted progenitor cells for treatment of neurological disorders.

  2010cited by this paper
• Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.

  2010cited by this paper
• Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells

  2010cited by this paper
• Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice

  2009cited by this paper
• Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice

  2009cited by this paper
• CERVICAL SPINAL CORD THERAPEUTICS DELIVERY: PRECLINICAL SAFETY VALIDATION OF A STABILIZED MICROINJECTION PLATFORM

  2009cited by this paper
• Transient Recovery in a Rat Model of Familial Amyotrophic Lateral Sclerosis after Transplantation of Motor Neurons Derived from Mouse Embryonic Stem Cells

  2009cited by this paper
• Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis

  2008cited by this paper
• Neuron-Specific Expression of Mutant Superoxide Dismutase Is Sufficient to Induce Amyotrophic Lateral Sclerosis in Transgenic Mice

  2008cited by this paper
• Focal Transplantation-based Astrocyte Replacement is Neuroprotective in a Model of Motor Neuron Disease

  2008cited by this paper
• Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.

  2008cited by this paper
• Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.

  2007cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS model

  2007cited by this paper
• GDNF Secreting Human Neural Progenitor Cells Protect Dying Motor Neurons, but Not Their Projection to Muscle, in a Rat Model of Familial ALS

  2007cited by this paper
• Adult Olfactory Bulb Neural Precursor Cell Grafts Provide Temporary Protection From Motor Neuron Degeneration, Improve Motor Function, and Extend Survival in Amyotrophic Lateral Sclerosis Mice

  2007cited by this paper
• Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

  2007cited by this paper
• Extensive Neuronal Differentiation of Human Neural Stem Cell Grafts in Adult Rat Spinal Cord

  2007cited by this paper
• Mutant SOD1G93A microglia are more neurotoxic relative to wild‐type microglia

  2007cited by this paper
• Human Neural Stem Cell Grafts Ameliorate Motor Neuron Disease in SOD-1 Transgenic Rats

  2006cited by this paper
• Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis

  2006cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia

  2006cited by this paper
• GDNF Delivery Using Human Neural Progenitor Cells in a Rat Model of ALS

  2005cited by this paper
• Iron oxide MR contrast agents for molecular and cellular imaging

  2004cited by this paper
• Accumulation of SOD1 Mutants in Postnatal Motoneurons Does Not Cause Motoneuron Pathology or Motoneuron Disease

  2002cited by this paper
• Neuron-Specific Expression of Mutant Superoxide Dismutase 1 in Transgenic Mice Does Not Lead to Motor Impairment

  2001cited by this paper
• A tripotential glial precursor cell is present in the developing spinal cord.

  1998cited by this paper
• Glial-restricted precursors are derived from multipotent neuroepithelial stem cells.

  1997cited by this paper
• Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

  1995cited by this paper
• A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group.

  1994cited by this paper
• Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

  1994cited by this paper
• Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.

  1992cited by this paper
• Intermittent Hypoxia and Stem Cell Implants Preserve Breathing Capacity in a Rodent Model of Amyotrophic Lateral Sclerosis at a Glance Commentary

  year unknowncited by this paper

• Glial Cells as Emerging Therapeutic Targets in Neurodegenerative Diseases: Mechanistic Insights and Translational Perspectives

  2025cites this paper
• Stem Cell Therapy for the Treatment of Amyotrophic Lateral Sclerosis: Comparison of the Efficacy of Mesenchymal Stem Cells, Neural Stem Cells, and Induced Pluripotent Stem Cells

  2024cites this paper
• Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies.

  2024cites this paper
• Therapeutical growth in oligodendroglial fate induction via transdifferentiation of stem cells for neuroregenerative therapy.

  2023cites this paper
• Therapeutic targeting of ALS pathways: Refocusing an incomplete picture

  2023cites this paper
• Overview of stem cells therapy in amyotrophic lateral sclerosis

  2021influential citation
• The panoramic view of amyotrophic lateral sclerosis: A fatal intricate neurological disorder.

  2021cites this paper
• Stem cell in neurodegenerative disorders; an emerging strategy

  2021cites this paper
• Tissue Engineering and Biomaterial Strategies to Elicit Endogenous Neuronal Replacement in the Brain

  2020cites this paper
• Astrocyte Diversity: Current Insights and Future Directions

  2020cites this paper
• Stem Cell Transplantation for Amyotrophic Lateral Sclerosis.

  2020cites this paper
• Stem Cell-based Therapy for Neurodegenerative Diseases

  2020cites this paper
• Amelioration of Amyotrophic Lateral Sclerosis in SOD1G93A Mice by M2 Microglia from Transplanted Marrow

  2019cites this paper
• Alzheimer's Disease and Other Neurodegenerative Diseases

  2019cites this paper
• SOD1/Rag2 Mice with Low Copy Number of SOD1 Gene as a New Long-Living Immunodeficient Model of ALS

  2019cites this paper
• Glia in amyotrophic lateral sclerosis and spinal cord injury: common therapeutic targets

  2019cites this paper
• Successes and Hurdles in Stem Cells Application and Production for Brain Transplantation

  2019cites this paper
• Biomaterials Developments for Brain Tissue Engineering.

  2018cites this paper
• An integrated biomanufacturing platform for the large-scale expansion and neuronal differentiation of human pluripotent stem cell-derived neural progenitor cells.

  2018cites this paper
• Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis.

  2018cites this paper
• Astrocyte Heterogeneity in the Adult Central Nervous System

  2018cites this paper
• The need for engineering neural tissue using stem cells

  2018cites this paper
• Addressing Cell Therapy for Spinal Muscular Atrophy: Open Issues and Future Perspectives

  2017cites this paper
• ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles

  2017cites this paper
• Ex vivo gene therapy for the treatment of neurological disorders.

  2017cites this paper
• Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications

  2017cites this paper
• Therapeutic strategies in neurodegenerative diseases

  2017cites this paper
• Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation

  2017cites this paper
• Endothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier Repair

  2017cites this paper
• Cord blood as a potential therapeutic for amyotrophic lateral sclerosis

  2017cites this paper
• Treatment of refractory epilepsy patients with autologous mesenchymal stem cells reduces seizure frequency: An open label study.

  2017cites this paper
• Distributed Features of Vimentin-Containing Neural Precursor Cells in Olfactory Bulb of SOD1G93A Transgenic Mice: a Study about Resource of Endogenous Neural Stem Cells

  2016cites this paper
• Juxtacerebral Tissue Regeneration Potential: Telocytes Contribution.

  2016cites this paper
• Co-transplantation of syngeneic mesenchymal stem cells improves survival of allogeneic glial-restricted precursors in mouse brain.

  2016cites this paper
• A molecular dissection of neuroinflammation in ovine Batten disease

  2016cites this paper
• Human neural progenitors differentiate into astrocytes and protect motor neurons in aging rats.

  2016cites this paper
• The Neuroprotective and Therapeutic Effects of Anthocyanins and Their Metabolites In Vitro and in a Mouse Model of Amyotrophic Lateral Sclerosis

  2016cites this paper
• Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models

  2016cites this paper
• Title Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington ' s Disease Mouse Models

  2016cites this paper
• Autologous mesenchymal stromal cells as a therapeutic in ALS and epilepsy patients: Treatment modalities and ex vivo neural differentiation.

  2016cites this paper
• Neural stem cell transplantation in ALS: developing a cure for the incurable?

  2016cites this paper
• Astroglia in Thick Tissue with Super Resolution and Cellular Reconstruction

  2016cites this paper
• Neural Stem Cells and their Niches in Neuroregeneration

  2015influential citation